For the reason that cardiac hypertrophy and inflammation are associated with myocardial fibrosis and injury, it is conceivable to think that SIRT6 is an antifibrotic and antiinflammatory sirtuin whose upregulation may help to impede the development of fibrosis- and inflammation-related diseases. This evidence concerns the gene SIRT6 and cardiac hypertrophy.